Background—Despite rapid clinical translation and widespread enthusiasm, the therapeutic
benefits of adult bone marrow cell (BMC) transplantation in patients with ischemic heart …

Rationale: Notwithstanding the uncertainties about the outcomes of bone marrow cell (BMC)
therapy for heart repair, further insights are critically needed to improve this promising …

Background The results from small clinical studies suggest that therapy with adult bone
marrow (BM)–derived cells (BMCs) reduces infarct size and improves left ventricular function …

Aims The objective of the present analysis was to systematically examine the effect of
intracoronary bone marrow cell (BMC) therapy on left ventricular (LV) function after ST …

Objective To evaluate bone marrow stem cell treatment (BMSC) in patients with ischemic
heart disease (IHD) and no option of revascularization. Background Autologous BMSC …

Background—The aim of this study was to investigate the clinical outcome 2 years after
intracoronary administration of autologous progenitor cells in patients with acute myocardial …

Background Pilot trials suggest that the intracoronary administration of autologous
progenitor cells may improve left ventricular function after acute myocardial infarction …

Aims Previous evaluation of autologous bone‐marrow stem‐cell (BMSC) therapy following
acute myocardial infarction (AMI) suggests that cell dose and timing of stem‐cell …

Background Experimental and clinical studies have suggested that intracoronary infusion of
bone marrow-derived stem/progenitor cells (BMC) may improve left ventricular function after …

Importance Stem cell therapy is a promising treatment strategy for patients with heart failure,
which accounts for more than 10% of deaths in the United States annually. Despite more …